Myasthenia Gravis
📧 Sign up to get email alerts when something new happens for Myasthenia Gravis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2026-01-21Clinical Trial Update: Tongji NADs Cohort
Tongji Hospital has announced a NADs cohort trial covering multiple autoimmune neurological diseases including multiple sclerosis and relate…
-
EMA approval · 2026-01-16EMA Authorised: Rystiggo (rozanolixizumab) — UCB Pharma
The European Medicines Agency authorised Rystiggo (rozanolixizumab) for myasthenia gravis, with orphan medicine designation.
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Proteomic Changes in Patients With Myasthenia Gravis and Ravulizumab
An update on a clinical trial studying proteomic changes in patients with Myasthenia Gravis treated with Ravulizumab, currently not recruiti…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Predictors of Myasthenia Gravis Outcome Following Thoracoscopic Thymectomy: Comparative Study Between Thymomatous and Non-Thymomatous Patients
A completed clinical study evaluating predictors of outcomes after thoracoscopic thymectomy for Myasthenia Gravis, comparing thymomatous and…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: SP Thoracic IDE Study [NA]
Clinical trial update for Intuitive Surgical's SP Thoracic IDE Study. Results have been posted and the trial is active but not recruiting, w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Psychological Health and Adverse Childhood Experiences in Myasthenia Gravis: Online Mental Health BMI Learning Program [NA]
A completed clinical trial evaluating an online mental health learning program focused on psychological health and adverse childhood experie…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases [EARLY_Phase 1]
A Phase 1 trial evaluating a universal CAR T-cell therapy targeting CD19 and BCMA in relapsed/refractory neurological autoimmune diseases, w…
-
EMA approval · 2025-12-12EMA Authorised: Imaavy (nipocalimab) — Janssen Cilag International NV
The European Medicines Agency has authorised Imaavy (nipocalimab) for the treatment of myasthenia gravis, on behalf of Janssen Cilag Interna…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Effectiveness and Safety of Zilucoplan Treatment for French Patients With Myasthenia Gravis Over 3 Months
A clinical trial updating on the effectiveness and safety of zilucoplan for French patients with myasthenia gravis over a three-month period…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: The EXPLORE MG Registry for Myasthenia Gravis
The EXPLORE MG Registry for Myasthenia Gravis at Yale University is currently recruiting participants to collect observational data on patie…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Evaluating Dyspnea in Autoimmune Myasthenia Gravis "Why am I Short of Breath?"
A clinical trial update outlines a planned study evaluating dyspnea in autoimmune myasthenia gravis. The trial is currently NOT_YET_RECRUITI…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Allogeneic CD19-CAR-NK Cells in Patients With Refractory Myasthenia Gravis [EARLY_Phase 1]
This update describes an early-phase trial evaluating allogeneic CD19-CAR-NK cells for refractory myasthenia gravis, with the study currentl…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: EFG vs IVIG in TAMG [Phase 3]
Phase 3 trial planned to compare efgartigimod against intravenous immunoglobulin in thymoma-associated myasthenia gravis, with recruitment n…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Quantification of Change in MG Disease Activity in Individuals With Generalized Myasthenia Gravis (gMG) After Administration of VYVGART® or VYVGART Hytrulo® Using BioDigit MG
Clinical trial update evaluating change in generalized myasthenia gravis activity after administration of VYVGART or VYVGART Hytrulo using B…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Multi-Modal Monitoring of Disease Symptoms in Myasthenia Gravis
BioSensics is conducting a multi-modal monitoring study of symptoms in myasthenia gravis, with the trial currently NOT_YET_RECRUITING.
-
FDA approval · 2025-10-17FDA Approved: VYVGART HYTRULO — Supplemental Application (argenx US)
FDA approved a supplemental application for Vyvgart Hytrulo, the fixed-dose combination of efgartigimod alfa and hyaluronidase (human recomb…
-
FDA approval · 2025-10-17FDA Approved: VYVGART — Supplemental Application (argenx US)
The FDA approved a supplemental application for Vyvgart (efgartigimod alfa) submitted by argenx US.
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: PPDTM CorEvitasTM Myasthenia Gravis (MG) Drug Safety and Effectiveness Registry
ClinicalTrials.gov registry entry for the PPDTM CorEvitas Myasthenia Gravis Drug Safety and Effectiveness Registry. Sponsored by CorEvitas, …
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC) [Phase 2]
Phase 2 clinical trial evaluating DNTH103 in adults with generalized myasthenia gravis is active but not currently recruiting.
-
FDA approval · 2025-09-26FDA Approved: PYRIDOSTIGMINE BROMIDE — Supplemental Application (Surgeon General-Department of the Army (TSG-DA))
FDA approved a supplemental application for pyridostigmine bromide submitted by the Surgeon General-Department of the Army (TSG-DA).
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod [Phase 4]
Phase 4 clinical trial in elderly patients with generalized myasthenia gravis evaluating whether efgartigimod can enable corticosteroid-spar…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Acupuncture in Myasthenia Gravis (AcuMG) [NA]
A completed clinical trial evaluating acupuncture for myasthenia gravis has posted results.
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study [EARLY_Phase 1]
Early-phase pilot study evaluating safety and preliminary efficacy of the JAK inhibitor tofacitinib in patients with refractory generalized …
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis [Phase 1]
A Phase 1 clinical trial is evaluating the safety and efficacy of a CD19-BCMA targeted CAR-T therapy for refractory generalized myasthenia g…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Study of Pyridostigmine With Ondansetron in Subjects With Anti-AchR Positive Myasthenia Gravis [Phase 2]
Phase 2 trial evaluating pyridostigmine with ondansetron in anti-AChR positive myasthenia gravis has been terminated.